JCOGの基本情報 > 研究実績 > 放射線治療グループ

JCOGの基本情報放射線治療グループ

更新日：2010年8月31日

  1. 論文
    1. 委員会承認の治療研究

      なし

    2. グループ代表者管理の治療研究

      Y Nagata, et al.: Clinical outcomes of a Phase I/II study of 48Gy of stereotactic body radiation therapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 63(5) : 1427-1431, 2005.

    3. 附随研究等
      • Nishio T, Kunieda E, Shirato H, et al. : Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer : Japan Clinical Oncology Group trial (JCOG0403). Phys Med Biol. 51: 5409-5417, 2006.
      • Matsuo Y, Takayama K, Nagata Y, et al. : Interinstitutional Variations in Planning for Stereotactic Body Radiation Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 68:416-425, 2007.
      • T Toita, M Oguchi, T Kodaira, et al.:Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer. The individual case review. Jpn J Clin Oncol. 39(12):813-819, 2009.
      • M Yamaguchi, M Oguchi, S Ishikura, et al.:Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol. 27：5594-5600, 2009.
      • Y Nishimura, T Shibata, K Nakamatsu, et al.:A two-step intensity modulated radiation therapy method for nasopharyngeal cancer: The Kinki University experience. Jpn J Clin Oncol. 40:130-138, 2010.
      • T Toita, T Ohno, Y Kaneyasu, et al.:A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer. Jpn J Clin Oncol. 40:456-463, 2010.
    4. 総説・解説
      • 佐野尚樹、佐々木潤一、西尾禎治、他：体幹部定位放射線治療「ガイドラインの詳細とマニュアル」 大西 洋、平岡真寛 編著. 中外医学社. 2006.
      • M Hiraoka, S Ishikura. A Japan Clinical Oncology Group Trial for Stereotactic Body Radiation Therapy of Non-Small Cell Lung Cancer. J Thorac Oncol. 2(7): S115-117, 2007.
      • K Nakamura, T Kodaira, N Shikama, et al.:Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study Japan Clinical Oncology Group study (JCOG 0701). Jpn J Clin Oncol. 38:387-389, 2008.
  2. 主な学会発表
    1. 委員会承認の治療研究

      なし

    2. グループ代表者管理の治療研究
      • なし
    3. 附随研究等
      • T Nishio, M Shimbo, E Kunieda, et al.: Quality assurance of radiotherapy treatment planning system prior to stereotactic irradiation for lung tumor trial : Japan Clinical Oncology Group (JCOG) study. The 23th ESTRO Meeting. 2004.
      • M Oguchi, Y Kagami, S Ishikura, et al.:Upfront radiotherapy with concurrent chemotherapy for localized nasal NK/T-cell lymphoma: Radiotherapy quality assurance (QA) review in Japan Clinical Oncology Group (JCOG) trial 0211. The 50th ASTRO Annual Meeting. 2008.
      • S Ishikura, M Hiraoka, W Bosch, et al.:Radiotherapy quality assurance (QA) in a multi-center stereotactic body radiation therapy (SBRT) trial for stage IA non-small cell lung cancer: The Japan Clinical Oncology Group (JCOG) trial 0403. Fourth International Conference on Translational Research and Pre-Clinical Strategies in Radiation Oncology (ICTR). 2009.
    4. 総説・解説
      • Y Nagata, M Hiraoka: A phase-II study of the stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer. 第10回日本高精度放射線外部照射研究会. 2004年7月.
      • 永田 靖、平岡真寛：JCOG0403 T1N0M0非小細胞肺癌に対する体幹部定位照射. 第14回日本定位放射線治療学会. 2005年9月.
      • M Hiraoka :A JCOG trial for SRT of NSCLC. International Association for the study of Lung Cancer Workshop. 2006.
      • 石倉聡．臨床試験(JCOG)における放射線治療の品質管理．第44回日本癌治療学会総会，シンポジウム「肺がんの化学療法・放射線療法：現在と未来」.2006年10月.
トップへ戻る